21/03/2024
PDPU can undertake the following services on either a collaborative or commercial basis (this list is not exhaustive):
- Production of antibodies and protein antigens from mouse, rat, human and insect cell lines
- Antibody engineering including isotype switching
- Antibody labelling e.g. FITC, RPE, AP
- Antibody fragmentation and fragment purification and labelling
Protein purification, scale up and QC validation to customer specification including low endotoxin conditions
- CE marking of derived reagents
- Development of customer cell lines, including optimisation and stability studies and mycoplasma testing
- New hybridoma and recombinant cell line generation, optimisation and stability studies
- Phage display library screening (using antigen provided by customer)
- Provision of IBGRL cell lines under a license agreement
- Diagnostic assay development, validation & qualification (including CE marking)
- Diagnostic platform development, validation & qualification
- Provision of IBGRL cell lines under a license agreement
If you would like to request a service that is not listed please contact us: Enquiries.IBGRL@nhsbt.nhs.uk
Please note: IBGRL does not currently undertake GMP manufacturing services but may support development of a GMP process. Where responses indicate a request for GMP manufacturing, IBGRL will pass details onto the Cellular & Molecular Therapies and/or Tissue & Eye Services functions of NHSBT.
